Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The pericentric inversion of chromosome 16 [inv(16)(p13q22)] is a characteristic karyotypic abnormality associated with acute myeloid leukemia, most commonly of the M4Eo subtype. The 16p and 16q breakpoints were pinpointed by yeast artificial chromosome and cosmid cloning, and the two genes involved in this inversion were identified. On 16q the inversion occurred near the end of the coding region for CBFβ, also known as PEBP2β, a subunit of a heterodimeric transcription factor regulating genes expressed in T cells; on 16p a smooth muscle myosin heavy chain (SMMHC) gene (MYH11) was interrupted. In six of six inv(16) patient samples tested, an in-frame fusion messenger RNA was demonstrated that connected the first 165 amino acids of CBFβ with the tail region of SMMHC. The repeated coiled coil of SMMHC may result in dimerization of the CBFβ fusion protein, which in turn would lead to alterations in transcriptional regulation and contribute to leukemic transformation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A fourth alteration, inv (16), is observed in AML of the M4Eo subtype (French-American-British classification) and indirectly targets AML-1B by fusing CBF-, the gene for the heterodimeric DNA binding partner of AML-1B (71), to the smooth muscle myosin heavy chain gene, MYH11 (35,64).”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [35]
In the citing paper
“Consistent with the hypothesis that the inv(16) product titrates AML-1B through physical interactions (35), CBF-- MYH11 represses AML-1B-dependent activation but has only minimal effects on C/EBP-␣.”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [35]
Citations
Cites
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
Martin-Zanca, D., Hughes, S. H., & Barbacid, M. (1986) · Nature · doi:10.1038/319743a0 · Cited by 803
Translocations Among Antibody Genes in Human Cancer
Leder, P., Battey, J., Lenoir, G., Moulding, C., Murphy, W., Potter, H., Stewart, T., & Taub, R. (1983) · Science · doi:10.1126/science.6356357 · Cited by 712
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., & Shigesada, K. (1993) · Virology · doi:10.1006/viro.1993.1262 · Cited by 493
Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomb, H. M., & Rowley, J. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309153091103 · Cited by 492
Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R., & Speck, N. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3324-3339.1993 · Cited by 435
Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia.
Rowley, J. D. (1973) · PubMed · Cited by 366
Research works printed but not linked: 1
- CALLEN, D.F., Precise localisation of the long arm breakpoint on the inv(16) of ANNL M4Eo and progress towards cloning this breakpoint, AMERICAN JOURNAL OF HUMAN GENETICS 51: A57 (1992).
Cited by
Items 201–300 of 778
Epstein-Barr Virus-Encoded RNAs: Key Molecules in Viral Pathogenesis
Iwakiri, D. (2014) · Cancers · doi:10.3390/cancers6031615 · Cited by 78
Zhang, Y.-W., Bae, S.-C., Huang, G., Fu, Y.-X., Lu, J., Ahn, M.-Y., Kanno, Y., Kanno, T., & Ito, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4133 · Cited by 77
Altered affinity of CBFβ-SMMHC for Runx1 explains its role in leukemogenesis
Lukasik, S. M., Zhang, L., Corpora, T., Tomanicek, S., Li, Y., Kundu, M., Hartman, K. L., Liu, P., Laue, T. M., Biltonen, R. L., et al. (2002) · Nature Structural Biology · doi:10.1038/nsb831 · Cited by 77
Self-citationSolution structure of core binding factor beta and map of the CBF alpha binding site.
Bushweller, J. H., Huang, X., Peng, J. W., & Speck, N. A. (1999) · Nature Structural Biology · doi:10.1038/10670 · Cited by 77
Prevalence and clinical correlations of MLL gene rearrangements in AML- M4/5
Bower, M., Parry, P. J., Carter, M., Lillington, D., AMESS, J. A. L., Lister, T. A., Evans, G. A., & Young, B. (1994) · Blood · doi:10.1182/blood.v84.11.3776.bloodjournal84113776 · Cited by 77
Molecular Genetics of Childhood Leukemias
Rubnitz, J. E., & Look, A. T. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199801000-00001 · Cited by 77
Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?
Paschka, P., & Döhner, K. (2013) · Hematology · doi:10.1182/asheducation-2013.1.209 · Cited by 75
Targeting the cytoskeleton against metastatic dissemination
Ruggiero, C., & Lalli, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09936-0 · Cited by 74
Core‐binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy
Solh, M., Yohe, S. L., Weisdorf, D. J., & Üstün, C. (2014) · American Journal of Hematology · doi:10.1002/ajh.23821 · Cited by 74
Adya, N., Castilla, L. H., & Liu, P. P. (2000) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0189 · Cited by 74
Self-citationDirect and Propagated Effects of Small Molecules on Protein–Protein Interaction Networks
Cesa, L. C., Mapp, A. K., & Gestwicki, J. E. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00119 · Cited by 74
Liu, P. P., Wijmenga, C., Hajra, A. K., Blake, T. B., Kelley, C. A., Adelstein, R. S., Bagg, A., Rector, J. T., Cotelingam, J. D., Willman, C. L., et al. (1996) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199606)16:2<77::aid-gcc1>3.0.co;2-# · Cited by 73
Self-citationRole of AML1/Runx1 in the pathogenesis of hematological malignancies
Kurokawa, M., & Hirai, H. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01364.x · Cited by 73
Core binding factor and its role in normal hematopoietic development
Speck, N. A. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200107000-00002 · Cited by 72
Libermann, T. A., Pan, Z., Akbarali, Y., Hetherington, C. J., Boltax, J., Yergeau, D. A., & Zhang, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24671 · Cited by 70
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
PEBP2-β/CBF-β–dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis
Wee, H.-J., Voon, D. C.-C., Bae, S.-C., & Ito, Y. (2008) · Blood · doi:10.1182/blood-2008-01-134122 · Cited by 69
on behalf of AML/MDS working party, K. S. O. H., Kim, H., Ahn, H. K., Jung, C. W., Moon, J. H., Park, C., Lee, K.-O., Kim, Y., Kim, Y.-K., Kim, H., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1580-5 · Cited by 69
MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA
Bousquet, M., Nguyen, D. T. T., Chen, C., Shields, L., & Lodish, H. F. (2012) · Haematologica · doi:10.3324/haematol.2011.061515 · Cited by 69
Tang, Y.-Y., Shi, J., Zhang, L., Davis, A., Bravo, J., Warren, A. J., Speck, N. A., & Bushweller, J. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007350200 · Cited by 68
Kundu, M., Chen, A., Anderson, S., Kirby, M., Xu, L., Castilla, L. H., Bodine, D., & Liu, P. P. (2002) · Blood · doi:10.1182/blood-2002-04-1064 · Cited by 68
Self-citationDrug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses
Islam, T., Rahman, M. R., Göv, E., Turanlı, B., Gülfidan, G., Haque, A., Arğa, K. Y., & Mollah, N. H. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0048 · Cited by 68
Cellular and Molecular Mechanisms of Environmental Pollutants on Hematopoiesis
Scharf, P. R. D. S., Broering, M. F., da Rocha, G. H. O., & Farsky, S. H. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21196996 · Cited by 68
The role of EBERs in oncogenesis
Takada, K., & Nanbo, A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0413 · Cited by 68
Manji, H. K., McNamara, R., Chen, G., & Lenox, R. H. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.1999.00670.x · Cited by 60
Myosins as fundamental components during tumorigenesis: diverse and indispensable
Li, Y.-R., & Yang, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8800 · Cited by 68
Zhang, L., Nguyen, L. X. T., Chen, Y., Wu, D., Cook, G., Hoang, D. H., Brewer, C., He, X., Dong, H., Li, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26420-7 · Cited by 67
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia
Kim, H., Kojima, K., Swindle, C. S., Cotta, C. V., Huo, Y., Reddy, V., & Klug, C. A. (2007) · Blood · doi:10.1182/blood-2006-06-030312 · Cited by 67
Coco, F. L., Pisegna, S., & Diverio, D. (1997) · PubMed · Cited by 67
Okuda, T., Takeda, K., Fujita, Y., Nishimura, M., Yagyu, S., Yoshida, M., Akira, S., Downing, J. R., & Abe, T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.319-328.2000 · Cited by 66
The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1
Frank, R. C., Sun, X., Berguido, F. J., Jakubowiak, A. J., & Nimer, S. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202459 · Cited by 66
RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes
Koh, C. P., Wang, C. Q., Ng, C. E. L., Ito, Y., Araki, M., Tergaonkar, V., Huang, G., & Osato, M. (2013) · Leukemia · doi:10.1038/leu.2013.200 · Cited by 65
Alterations of the AML1 transcription factor in human leukemia
Downing, J. R., Higuchi, M., Lenny, N. T., & Yeoh, A. E. J. (2000) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0183 · Cited by 64
Clinical Significance of the Most Common Chromosome Translocations in Adult Acute Myeloid Leukemia
Mrózek, K., & Bloomfield, C. D. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn003 · Cited by 64
Yin, J. A. L., & Tobal, K. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01522.x · Cited by 64
The Molecular Genetics of Recurring Chromosome Abnormalities in Acute Myeloid Leukemia
Hayashi, Y. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90017-9 · Cited by 64
CONSEQUENCES OF CHROMOSOMAL ABNORMALITIES IN TUMOR DEVELOPMENT
Sánchez-García, I. (1997) · Annual Review of Genetics · doi:10.1146/annurev.genet.31.1.429 · Cited by 64
Biochemical and Biophysical Properties of the Core-binding Factor α2 (AML1) DNA-binding Domain
Crute, B. E., Lewis, A. F., Wu, Z., Bushweller, J. H., & Speck, N. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26251 · Cited by 62
Detection of minimal residual disease
Dölken, G. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)82005-4 · Cited by 62
Krauter, J., Peter, W., Pascheberg, U., Heinze, B., Bergmann, L., Hoelzer, D. F., Lübbert, M., Schlimok, G., Arnold, R., Kirchner, H. H., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00926.x · Cited by 62
Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter
Uchida, H., Downing, J. R., Miyazaki, Y., Frank, R. C., Zhang, J., & Nimer, S. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202383 · Cited by 62
Mutation-associated fusion cancer genes in solid tumors
Kaye, F. J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0135 · Cited by 61
Strout, M. P., Marcucci, G., Caligiuri, M. A., & Bloomfield, C. D. (1999) · Annals of Hematology · doi:10.1007/s002770050511 · Cited by 61
The TEL gene and human leukemia
Golub, T. R., McLean, T. W., Stegmaier, K., Carroll, M. C., Tomasson, M. H., & Gilliland, D. G. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00015-7 · Cited by 61
Fujita, Y., Nishimura, M., Taniwaki, M., Abe, T., & Okuda, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4513 · Cited by 60
Structural and Functional Characterization of the Human CD36 Gene Promoter
Armesilla, A. L., Calvo, D., & Vega, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7781 · Cited by 60
Matsuno, N., Osato, M., Yamashita, N., Yanagida, M., Nanri, T., Fukushima, T., Motoji, T., KUSUMOTO, S., Towatari, M., Suzuki, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403160 · Cited by 60
van der Reijden, B., Lombardo, M. A., Dauwerse, H., Giles, R. H., Mühlematter, D., Bellomo, M., Wessels, H. W., Beverstock, G. C., van Ommen, G. B., & Hagemeijer, A. (1995) · Blood · doi:10.1182/blood.v86.1.277.bloodjournal861277 · Cited by 60
Lou, J., Cao, W., Bernardin, F., Ayyanathan, K., Rauscher, F. J., & Friedman, A. D. (2000) · Oncogene · doi:10.1038/sj.onc.1203588 · Cited by 60
Cameron, S., Taylor, D., TePas, E., Speck, N., & Mathey-Prevot, B. (1994) · Blood · doi:10.1182/blood.v83.10.2851.2851 · Cited by 59
Nishimura, M., Fukushima‐Nakase, Y., Fujita, Y., Nakao, M., Toda, S., Kitamura, N., Abe, T., & Okuda, T. (2003) · Blood · doi:10.1182/blood-2003-06-2109 · Cited by 59
Fukuyama, T., Sueoka, E., Sugio, Y., Otsuka, T., Niho, Y., Akagi, K., & Kozu, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204794 · Cited by 59
Namba, K., Abé, M., Saito, S., Satake, M., Ohmoto, T., Watanabe, T., & Sato, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203257 · Cited by 59
Schwind, S., Edwards, C. G., Nicolet, D., Mrózek, K., Maharry, K. S., Wu, Y.-Z., Paschka, P., Eisfeld, A., Hoellerbauer, P., Becker, H., et al. (2012) · Blood · doi:10.1182/blood-2012-07-442772 · Cited by 58
The phosphorylation state of an autoregulatory domain controls PACS‐1‐directed protein traffic
Scott, G. K., Gu, F., Crump, C. M., Thomas, L., Wan, L., Xiang, Y. K., & Thomas, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg596 · Cited by 58
Runx family genes, niche, and stem cell quiescence
Wang, C. Q., Jacob, B., Nah, G. S. S., & Osato, M. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.01.006 · Cited by 57
Lane, S., Saal, R. J., Mollee, P. N., Jones, M., Grigg, A., Taylor, K. M., Seymour, J. F., Kennedy, G., Williams, B., Grimmett, K., et al. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701817266 · Cited by 57
Self-citationEpidemiology and clinical burden of acute myeloid leukemia
Redaelli, A. C. L., Lee, J. M., Stephens, J., & Pashos, C. L. (2003) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.3.5.695 · Cited by 57
Zaiman, A. L., Lewis, A. F., Crute, B. E., Speck, N. A., & Lenz, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2898-2906.1995 · Cited by 53
Multifunctional non-coding Epstein–Barr virus encoded RNAs (EBERs) contribute to viral pathogenesis
Iwakiri, D. (2015) · Virus Research · doi:10.1016/j.virusres.2015.08.007 · Cited by 56
Regulation of GM-CSF gene transcription by core-binding factor.
Cockerill, P. N., Osborne, C. S., Bert, A. G., & Grotto, R. J. (1996) · PubMed · Cited by 56
Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice
Hyde, R. K., Zhao, L., Alemu, L., & Liu, P. P. (2015) · Leukemia · doi:10.1038/leu.2015.58 · Cited by 55
Self-citationCuenco, G. M., & Ren, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207143 · Cited by 55
Marcucci, G., Caligiuri, M. A., & Bloomfield, C. D. (2000) · Cancer Investigation · doi:10.3109/07357900009012209 · Cited by 55
Liu, K., Hu, H., Jiang, H., Zhang, H., Gong, S., Wei, D., & Yu, Z. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa116 · Cited by 54
Core Binding Factor Acute Myeloid Leukemia: New Prognostic Categories and Therapeutic Opportunities
Sinha, C., Cunningham, L., & Liu, P. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.04.002 · Cited by 54
Self-citationinv(16)(p13q22) in Chronic Myelogenous Leukemia in Blast Phase
Merzianu, M., Medeiros, L. J., Cortes, J. E., Yin, C. C., Lin, P., Jones, D. M., Glassman, A. B., Kantarjian, H. M., & Huh, Y. O. (2005) · American Journal of Clinical Pathology · doi:10.1309/3hfe16dkmb1dbfmn · Cited by 54
Fusion genes in leukemia: an emerging network
Bohlander, S. K. (2000) · Cytogenetic and Genome Research · doi:10.1159/000056818 · Cited by 54
Molecular genetics of acute leukaemia
Sawyers, C. L. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07535-6 · Cited by 54
Cierpicki, T., & Grembecka, J. (2015) · Immunological Reviews · doi:10.1111/imr.12244 · Cited by 53
Hyde, R. K., Kamikubo, Y., Anderson, S. M., Kirby, M., Alemu, L., Zhao, L., & Liu, P. (2009) · Blood · doi:10.1182/blood-2009-06-227413 · Cited by 53
Self-citationAllford, S. L., Grimwade, D. J., Langabeer, S. E., Duprez, E., Saurin, A. J., Chatters, S., Walker, H., Roberts, P. J., Rogers, J., Bain, B. J., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01312.x · Cited by 53
AML1 Interconnected Pathways of Leukemogenesis: MOLECULAR BIOLOGY AND GENETICS
Michaud, J., Scott, H. S., & Escher, R. (2003) · Cancer Investigation · doi:10.1081/cnv-120018821 · Cited by 53
Function of the inv(16) fusion gene CBFB-MYH11
Kundu, M., & Liu, P. P. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200107000-00004 · Cited by 53
Self-citationGozzini, A., Rovida, E., Sbarba, P. D., Galimberti, S., Santini, V., & Galimbert, S. (2003) · PubMed · Cited by 53
Zaiman, A., & Lenz, J. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5618-5629.1996 · Cited by 53
Bae, S.-C., Ogawa, E., Maruyama, M., Oka, H., Satake, M., Shigesada, K., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., & Ito, Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3242-3252.1994 · Cited by 52
Baum, C., Itoh, K., Meyer, J., Laker, C., Ito, Y., & Ostertag, W. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6323-6331.1997 · Cited by 52
Cheng, C. K., Li, L., Cheng, S. H., Lau, K., Chan, N. P. H., Wong, R. S. M., Shing, M. M. K., Li, C. K., & Ng, M. H. L. (2008) · Blood · doi:10.1182/blood-2008-02-137083 · Cited by 52
Haas, B. J., Dobin, A., Ghandi, M., Arsdale, A. V., Tickle, T. L., Robinson, J., Gillani, R., Kasif, S., & Regev, A. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100467 · Cited by 51
RUNX1: A MicroRNA Hub in Normal and Malignant Hematopoiesis
Rossetti, S., & Sacchi, N. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011566 · Cited by 51
Accelerated Leukemogenesis by Truncated CBFβ-SMMHC Defective in High-Affinity Binding with RUNX1
Kamikubo, Y., Zhao, L., Wunderlich, M., Corpora, T., Hyde, R. K., Paul, T. A., Kundu, M., Garrett, L. J., Compton, S. T., Huang, G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.022 · Cited by 51
Self-citationAML1 stimulates G1 to S progression via its transactivation domain
Bernardin, F., & Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205447 · Cited by 51
Wunderlich, M., Krejci, O., Wei, J.-P., & Mulloy, J. C. (2006) · Blood · doi:10.1182/blood-2005-12-012773 · Cited by 51
KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice
Zhao, L., Melenhorst, J. J., Alemu, L., Kirby, M., Anderson, S. M., Kench, M., Hoogstraten-Miller, S. L., Brinster, L., Kamikubo, Y., Gilliland, D. G., et al. (2011) · Blood · doi:10.1182/blood-2011-02-338210 · Cited by 50
Self-citationInvestigating human leukemogenesis: from cell lines to in vivo models of human leukemia
Kennedy, J. A., & Barabé, F. (2008) · Leukemia · doi:10.1038/leu.2008.206 · Cited by 50
Ritter, M., Thiede, C., Schäkel, U., Schmidt, M., Alpen, B., Pascheberg, U., Mohr, B., Ehninger, G., Neubauer, A., & for the AML‐SHG study group (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2933107.x · Cited by 50
Taki, T., Akiyama, M., Saito, S., Ono, R., Taniwaki, M., Kato, Y., Yuza, Y., Eto, Y., & Hayashi, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208711 · Cited by 49
The AML1 and ETO Genes in Acute Myeloid Leukemia with a t(8;21)
Nucifora, G., & Rowley, J. D. (1994) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199409049690 · Cited by 49
Tanaka, K., Tanaka, T., Kurokawa, M., Imai, Y., Ogawa, S., Mitani, K., Yazaki, Y., & Hirai, H. (1998) · Blood · doi:10.1182/blood.v91.5.1688 · Cited by 48
Wijmenga, C., Speck, N. A., Dracopoli, N. C., Hofker, M. H., Liu, P., & Collins, F. S. (1995) · Genomics · doi:10.1016/0888-7543(95)80185-o · Cited by 48
Self-citationSpecial Article: Gene Rearrangements in Ewing's Sarcoma
Denny, C. T. (1996) · Cancer Investigation · doi:10.3109/07357909609018438 · Cited by 48
Mouse Chromosome Engineering for Modeling Human Disease
van der Weyden, L., & Bradley, A. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.7.080505.115741 · Cited by 47
Kurokawa, M., Tanaka, T. U., Tanaka, K., Hirano, N., Ogawa, S., Mitani, K., Yazaki, Y., & Hirai, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16870 · Cited by 47
Nagata, T., & Werner, M. H. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4596 · Cited by 47
Physical and functional link of the leukemia-associated factors AML1 and PML
Nguyen, L. A., Pandolfi, P. P., Aikawa, Y., Tagata, Y., Ohki, M., & Kitabayashi, I. (2004) · Blood · doi:10.1182/blood-2004-03-1185 · Cited by 46
Eosinophilia Associated with Clonal T-Cell Proliferation
Kitano, K., Ichikawa, N., Shimodaira, S., Ito, T., Ishida, F., & Kiyosawa, K. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709059688 · Cited by 46
Cao, W., Adya, N., Britos-Bray, M. F., Liu, P., & Friedman, A. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31534 · Cited by 46
Self-citationLi, L.-H., & Gergen, J. P. (1999) · Development · doi:10.1242/dev.126.15.3313 · Cited by 45
The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets
Hu, J., Zhou, L., Song, Z., Xiong, M., Zhang, Y., Yang, Y., Chen, K., & Chen, Z. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28208 · Cited by 45
Metadata
- Authors
- Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Science
- Published
- 1993-08-20
- Volume
- 261
- Issue
- 5124
- Pages
- 1041-1044
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2047591593
- Cited by
- 732
- References
- 37
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 7 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 15 · 2019: 13 · 2018: 8 · 2017: 24 · 2016: 8 · 2015: 23 · 2014: 18 · 2013: 14 · 2012: 15
- FWCI
- 25.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-55164, P01CA055164)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- acute myeloid leukemia, inv(16)(p13q22), CBFβ, smooth muscle myosin heavy chain, MYH11, gene fusion, transcription factors, coiled-coil dimerization, leukemic transformation, karyotype abnormalities
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 16, Cloning, Molecular, Cosmids, DNA-Binding Proteins, Humans, Chromosome Inversion, Molecular Sequence Data, Muscle, Smooth, Myosins, Neoplasm Proteins, Transcription Factors, Restriction Mapping, Leukemia, Myelomonocytic, Acute, Polymerase Chain Reaction, In Situ Hybridization, Fluorescence, Transcription Factor AP-2, Core Binding Factor beta Subunit, Core Binding Factor Alpha 1 Subunit, Core Binding Factors, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.